GLAXO SMITH KLINEGLAXO SMITH KLINEGLAXO SMITH KLINE

GLAXO SMITH KLINE

No trades
See on Supercharts

BIOC fundamentals

GLAXO SMITH KLINE financial statements, including revenue, expenses, profit, and loss

The total revenue of BIOC for the last quarter is 576.44 M EGP, and it's 6.82% higher compared to the previous quarter. The net income of Q3 23 is 27.16 M EGP.

Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth